Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1

[1]  N. de Vries,et al.  Memory CD4(+)CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1. , 2012, Blood.

[2]  H. Toyoda,et al.  Possible Roles of Proinflammatory and Chemoattractive Cytokines Produced by Human Fetal Membrane Cells in the Pathology of Adverse Pregnancy Outcomes Associated with Influenza Virus Infection , 2012, Mediators of inflammation.

[3]  H. A. Schreiber,et al.  An epigenetic silencing pathway controlling T helper 2 cell lineage commitment , 2012, Nature.

[4]  M. Monze,et al.  Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in Zambia , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Michael K Skinner,et al.  Environmental epigenetic transgenerational inheritance and somatic epigenetic mitotic stability , 2011, Epigenetics.

[6]  C. Jones,et al.  Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. , 2011, JAMA.

[7]  T. Kanneganti.  Central roles of NLRs and inflammasomes in viral infection , 2010, Nature Reviews Immunology.

[8]  T. Kuijpers,et al.  Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. , 2010, AIDS research and human retroviruses.

[9]  A. Marchant,et al.  High Incidence of Invasive Group B Streptococcal Infections in HIV-Exposed Uninfected Infants , 2010, Pediatrics.

[10]  M. Cotton,et al.  Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency. , 2010, Journal of tropical pediatrics.

[11]  R. Heyderman,et al.  Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants , 2010, Immunology.

[12]  V. Appay,et al.  Phenotype and function of human T lymphocyte subsets: Consensus and issues , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[13]  P. Iliff,et al.  Maternal Herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study , 2008, AIDS.

[14]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[15]  J. Pinto,et al.  Infectious Disease Morbidity Among Young HIV-1–Exposed But Uninfected Infants in Latin American and Caribbean Countries: The National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study , 2007, Pediatrics.

[16]  M. Clerici,et al.  Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. , 2006, Journal of reproductive immunology.

[17]  D. Patel,et al.  Chemokines and leukocyte trafficking in rheumatoid arthritis. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.

[18]  T. Kuijpers,et al.  Haematological parameters of HIV‐1‐uninfected infants born to HIV‐1‐infected mothers , 2005, Acta paediatrica.

[19]  M. Newell,et al.  Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers , 2005, AIDS.

[20]  M. Newell,et al.  Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Chang H. Kim.  Chemokine-chemokine receptor network in immune cell trafficking. , 2004, Current drug targets. Immune, endocrine and metabolic disorders.

[22]  T. Kuijpers,et al.  Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers , 2004, AIDS.

[23]  Antonio Lanzavecchia,et al.  Chemokine Receptor Expression Identifies Pre–T Helper (Th)1, Pre–Th2, and Nonpolarized Cells among Human CD4+ Central Memory T Cells , 2004, The Journal of experimental medicine.

[24]  C. Guihenneuc‐Jouyaux,et al.  Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants , 2003, AIDS.

[25]  B. Walker,et al.  Immunopathogenesis and immunotherapy in AIDS virus infections , 2003, Nature Medicine.

[26]  M. Stevenson.  HIV-1 pathogenesis , 2003, Nature Medicine.

[27]  F. Sallusto,et al.  Cytokine-driven proliferation and differentiation of human naïve, central memory and effector memory CD4+ T cells. , 2003, Pathologie-biologie.

[28]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[29]  M. Clerici,et al.  T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. , 2000, Blood.

[30]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[31]  M. Dybul,et al.  Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy , 1999, Nature Medicine.

[32]  Anthony S. Fauci,et al.  Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines , 1998, The Journal of experimental medicine.

[33]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[34]  R. Rydman,et al.  Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers , 1997, Clinical and diagnostic laboratory immunology.

[35]  W. Johnson,et al.  Differential Effects of Interleukin-12 , Interleukin-15 , and Interleukin-2 on Human Immunodeficiency Virus Type 1 Replication In Vitro , 1996 .

[36]  D. Venzon,et al.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.

[37]  U. Unicef,et al.  Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. , 2011 .

[38]  V. Soriano,et al.  [Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy]. , 2009, Medicina clinica.

[39]  J. H. Pope,et al.  Interleukin-2 enhances production in 24 hours of infectious human immunodeficiency virus type 1 in vitro by naturally infected mononuclear cells from seropositive donors , 2005, Archives of Virology.

[40]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.